Skip to content

The Effects of Caffeine on Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion

The Effects of Caffeine on DIEP Flap Perfusion: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04249934
Enrollment
0
Registered
2020-01-31
Start date
2020-02-15
Completion date
2020-03-16
Last updated
2021-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Deep Inferior Epigastric Perforator, Microvascular Free Flap Transfer

Brief summary

Women that require breast reconstruction and meet eligibility will be enrolled in this study. The study is being completed to determine the effect of caffeine in deep inferior epigastric perforator (DIEP) flap perfusion using the Vioptix tissue oximeter monitor and to determine if caffeine in the acute postoperative period affects overall flap complication or loss (complete loss from anastomotic issue). The researchers hypothesize that a single 8 ounce cup of regular coffee will not affect free flap perfusion as indicated by the Vioptix, and that it will not affect overall free flap survival at thirty days.

Interventions

DIETARY_SUPPLEMENTCaffeinated Coffee

A single 8 ounce cup of regular starbucks coffee will be given to the participant in the am post operative day two. Participants will have 15 minutes to consume the coffee. Additionally, medical record data will be collected up to 30 days after surgery.

DIETARY_SUPPLEMENTDecaffeinatedCoffee

A single 8 ounce cup of decaffeinated starbucks coffee will be given to the participant in the am post operative day two. Participants will have 15 minutes to consume the coffee. Additionally, medical record data will be collected up to 30 days after surgery.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Patient and observer will be blinded to which group they were assigned.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* regular caffeine consumers undergoing unilateral or bilateral microsurgical breast reconstruction with DIEP flap(s) at the University of Michigan Health System

Exclusion criteria

* smokers * hepatic or renal disease (comorbidities that affect caffeine metabolism) * male

Design outcomes

Primary

MeasureTime frameDescription
Analysis of feasibilityapproximately 6 months after recruitment startsThe total number of patients recruited per month, the rate of successful enrollment, and the rate of successful study completion will be evaluated.
Absolute value of tissue oxygenation saturation (StO2)up to 165 minutes (30 minutes prior to coffee consumption, 15 minutes for coffee consumption, 120 more minutes after consumption)St02 will be measured using the Vioptix tissue oximeter monitor. These will be summarized using means and standard deviations.
Absolute value of tissue oxygenation saturation (StO2) rate of changeup to 165 minutes (30 minutes prior to coffee consumption, 15 minutes for coffee consumption, 120 more minutes after consumption)St02 will be measured using the Vioptix tissue oximeter monitor. These will be summarized using means and standard deviations.
Absolute value of tissue oxygenation saturation (StO2) amount of changeup to 165 minutes (30 minutes prior to coffee consumption, 15 minutes for coffee consumption, 120 more minutes after consumption)St02 will be measured using the Vioptix tissue oximeter monitor. These will be summarized using means and standard deviations.

Secondary

MeasureTime frameDescription
Incidence of minor flap complications in the caffeine and non-caffeine groupsup to 30 days post-operativelyThe complications will include delayed wound healing, wound dehiscence, hematoma, seroma formation, and infections requiring antibiotics.
Incidence of major flap complications in the caffeine and non-caffeine groupsup to 30 days post-operativelyThese complications will include any event that results in an unplanned trip to the operating room (e.g. arterial or venous thrombosis), and flap loss (e.g. flap failure, flap death).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026